AZD9150
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for AZD9150, covering 2017-05-15 to 2024-08-21. Get the full timeline:
Most recent: Clinical Trial Update: AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer [Phase 1]